Get started
Author

Thomas Hueso

Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19
2020 · Thomas Hueso, Cécile Pouderoux, et al. · Blood · 281
PDF
Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with non‐Hodgkin lymphoma treated with B‐cell depleting immunotherapy
2021 · Rémy Duléry, Sylvain Lamure, et al. · American Journal of Hematology · 150
PDF
Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort
2020 · Laurence Albiges, Stéphanie Foulon, et al. · Nature Cancer · 115
PDF
Modulation of host defence against bacterial and viral infections by omega-3 polyunsaturated fatty acids
2016 · Marie-Odile Husson, Delphine Ley, et al. · Journal of Infection · 103
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review
2024 · Arthur Géraud, Thomas Hueso, et al. · European Journal of Cancer · 84
Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening
2020 · Thomas Hueso, Kenneth Ekpe, et al. · Gut Microbes · 76
PDF
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis
2022 · Thomas Hueso, Anne-Sophie Godron, et al. · Leukemia · 68
PDF
Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies
2021 · F. Pommeret, J. Colomba, et al. · Annals of Oncology · 34
Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers
2020 · Thomas Hueso, Thomas Gastinne, et al. · Bone Marrow Transplantation · 24
Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient
2021 · Tali-Anne Szwebel, David Veyer, et al. · Stem Cell Reviews and Reports · 22
PDF
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial
2023 · Karine Lacombe, Thomas Hueso, et al. · BMJ Medicine · 19
PDF
Citrulline and Monocyte-Derived Macrophage Reactivity before Conditioning Predict Acute Graft-versus-Host Disease
2017 · Thomas Hueso, Valérie Coiteux, et al. · Transplantation and Cellular Therapy · 19
PDF
Severe COVID-19 in patients with hematological cancers presenting with viremia
2021 · J.M. Michot, T. Hueso, et al. · Annals of Oncology · 16
Association Between Low Plasma Level of Citrulline Before Allogeneic Hematopoietic Cell Transplantation and Severe Gastrointestinal Graft vs Host Disease
2017 · Thomas Hueso, Jordan Gauthier, et al. · Clinical Gastroenterology and Hepatology · 11
Abstract S09-02: High incidence of persistent COVID-19 among patients with lymphoma treated with B-cell depleting immunotherapy
2021 · Sylvain Lamure, Remy Dulery, et al. · Clinical Cancer Research · 8
Nutritional interventions in patients with graft-versus-host disease
2023 · David Seguy, Thomas Hueso · Current Opinion in Clinical Nutrition & Metabolic Care · 7
COVID-19 convalescent plasma to treat hospitalised COVID-19 patients with or without underlying immunodeficiency: a randomized trial
2022 · Karine Lacombe, Thomas Hueso, et al. · medRxiv · 7
PDF
Engaging Innate Immunity By AFM28, an Innate Cell Engager (ICE®) Targeting CD123-Positive Leukemic Cells in Patients with Relapsed/Refractory Acute Myeloid Leukemia: Safety and Efficacy Results of a First-in-Human Phase 1 Study
2024 · Pau Montesinos, Montserrat Arnan, et al. · Blood · 5
PDF
Convalescent plasma treatment of B-cell depleted patients with COVID-19: systematic review and individual participant data meta-analysis
2025 · Solomiia Zaremba, Daniele Focosi, et al. · medRxiv · 4
Convalescent Plasma Therapy in Immunocompromised Patients Infected With the BA.1 or BA.2 Omicron SARS‐CoV‐2
2024 · Quentin Richier, Benjamin De Valence, et al. · Influenza and Other Respiratory Viruses · 4
PDF
Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study
2022 · Domitille Costes-Tertrais, Thomas Hueso, et al. · Bone Marrow Transplantation · 4
COVID-19 convalescent plasma for B-cell depleted patients: a systematic review and individual patient data meta-analysis
2025 · Solomiia Zaremba, Daniele Focosi, et al. · Frontiers in Medicine · 3
PDF
Secondary haemophagocytic lymphohistiocytosis is a rare occurrence amongst cancer patients with COVID‐19
2020 · Thomas Hueso, Clémentine Bouchez, et al. · British Journal of Haematology · 3
PDF
Bortezomib, Rituximab and Dexamethasone Regimen (BDR) in Waldenström Macroglobulinaemia: A Retrospective Real‐World Analysis
2025 · Thomas Hueso, Grégory Lazarian, et al. · eJHaem · 2
Treatment of Adverse-Risk and Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients with FLAG-IDA ± Venetoclax and CLAG-M: A Monocentric Experience
2023 · Ramy Rahmé, Valérie Vidal, et al. · Blood · 2
PDF
Works count: 66
Citation count: 1,076
H-index: 13
I10-index: 14
Year
Topic
Type